Humana Stock Forecast for 2022 - 2025 - 2030

Updated on 12/08/2022

Stock Rating
15
Price Target
$620.00
Consensus
Outperform
Upside
13.27%
Analysts
11
Stock Rating
15
Upside
13.27%
Analysts
11
Price Target
$620.00

Humana Stock Forecast and Price Target

The average price target for Humana's stock set by eleven recognized analysts recently is $620.00, which would result in a potential upside of approximately 13.27% if it reached this mark. The estimation is based on a high estimate of $650.00 and a low estimate of $450.00. If you are interested in HUM stock, it is important to also consider its competitors.

$620.00

13.27% Upside

Outperform
Outperform

Humana Fair Value Forecast for 2022 - 2025 - 2030

In the last three years, Price for Humana has grown by 41.86%, going from $302.93 to $429.72. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $502.80 – an increase of 17.01%. Over the next nine years, experts anticipate that Fair Value growth for Humana will be 177.42%.

2022 Fair Value Forecast
$502.80
2023 Fair Value Forecast
$570.88
2024 Fair Value Forecast
$640.84
2025 Fair Value Forecast
$730.78
2026 Fair Value Forecast
$817.19
2027 Fair Value Forecast
$881.52
2028 Fair Value Forecast
$978.75
2029 Fair Value Forecast
$1.08k
2030 Fair Value Forecast
$1.19k
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MSFT Stock Forecast Microsoft Buy 18
$247.40 Buy/Sell $296.98 17.22%
BRK.A Stock Forecast Berkshire Hathaway Outperform 9
$462.78k Buy/Sell $530.86k 17.24%
UNH Stock Forecast UnitedHealth Group Outperform 16
$547.92 Buy/Sell $579.33 9.05%
WMT Stock Forecast Walmart Outperform 14
$148.78 Buy/Sell $168.96 8.55%
CVS Stock Forecast CVS Health Outperform 13
$102.53 Buy/Sell $118.48 15.09%

Humana Revenue Forecast for 2022 - 2025 - 2030

In the last three years, Revenue for Humana has grown by 47.94%, going from $56.91B to $84.19B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $92.53B – an increase of 9.91%. Over the next nine years, experts anticipate that Revenue growth for Humana will be 88.65%.

2022 Rev Forecast
$92.53B
2023 Rev Forecast
$100.77B
2024 Rev Forecast
$110.32B
2025 Rev Forecast
$121.37B
2026 Rev Forecast
$133.27B
2027 Rev Forecast
$130.88B
2028 Rev Forecast
$139.63B
2029 Rev Forecast
$148.93B
2030 Rev Forecast
$158.83B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ANTM Stock Forecast Anthem Buy 13
$529.12 Buy/Sell $544.63 7.92%
CI Stock Forecast Cigna Outperform 13
$333.50 Buy/Sell $295.91 7.05%
MET Stock Forecast MetLife Outperform 16
$73.61 Buy/Sell $74.25 12.76%

Humana Dividend per Share Forecast for 2022 - 2025 - 2030

Humana's Dividend per Share has grown in the last three years, jumping from $2.00 to $2.80 – an increase of 40.00%. In the next year, analysts predict that Dividend per Share will reach $2.88 – an increase of 2.86%. For the next nine years, the forecast is for Dividend per Share to grow by 117.86%.

2022 DPS Forecast
$2.88
2023 DPS Forecast
$3.24
2024 DPS Forecast
$6.03
2025 DPS Forecast
$3.71
2026 DPS Forecast
$4.11
2027 DPS Forecast
$4.55
2028 DPS Forecast
$5.06
2029 DPS Forecast
$5.56
2030 DPS Forecast
$6.10
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CNC Stock Forecast Centene Outperform 12
$86.49 Buy/Sell $95.95 15.62%
AIG Stock Forecast American International Group Outperform 13
$62.26 Buy/Sell $67.50 5.20%
AFL Stock Forecast Aflac Hold 13
$70.32 Buy/Sell $60.77 -1.88%

Humana Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last three years, Humana's Free Cash Flow has decreased from $1.56B to $946.00M – a 39.40% drop! For next year, the 3 analysts predict Free Cash Flow of $3.42B, which would mean an increase of 261.45%. Over the next nine years, the pros' prediction is Free Cash Flowof $6.42B, which would mean a nine-year growth forecast of 579.07%.

2022 FCF Forecast
$3.42B
2023 FCF Forecast
$4.36B
2024 FCF Forecast
$5.82B
2025 FCF Forecast
$4.67B
2026 FCF Forecast
$4.98B
2027 FCF Forecast
$5.31B
2028 FCF Forecast
$5.69B
2029 FCF Forecast
$6.05B
2030 FCF Forecast
$6.42B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PRU Stock Forecast Prudential Financial Hold 17
$101.60 Buy/Sell $99.69 3.35%
WBA Stock Forecast Walgreens Boots Alliance Hold 11
$40.90 Buy/Sell $40.85 -2.20%
CAH Stock Forecast Cardinal Health Hold 13
$80.78 Buy/Sell $58.69 -2.20%

Humana Net Income Forecast for 2022 - 2025 - 2030

In the last three years, Humana's Net Income has increased by 74.27%, going from $1.68B to $2.93B. In the next year, analysts are expecting an increase in Net Income, predicting it will reach $3.07B – an increase of 4.53%. The Humana forecast is for Net Income to reach $6.09B or grow by 107.62%.

2022 NI Forecast
$3.07B
2023 NI Forecast
$3.42B
2024 NI Forecast
$3.80B
2025 NI Forecast
$4.12B
2026 NI Forecast
$4.45B
2027 NI Forecast
$4.82B
2028 NI Forecast
$5.22B
2029 NI Forecast
$5.64B
2030 NI Forecast
$6.09B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MOH Stock Forecast Molina Healthcare Outperform 16
$339.75 Buy/Sell $328.38 8.90%
UHS Stock Forecast Universal Health Services Hold 11
$129.61 Buy/Sell $147.80 -7.41%
DVA Stock Forecast DaVita Hold 16
$74.91 Buy/Sell $124.50 0.79%

Humana EBITDA Forecast for 2022 - 2025 - 2030

Humana's EBITDA has increased by 36.30% In the last three years, going from $3.34B to $4.55B. In the next year, analysts expect EBITDA to reach $4.98B – an increase of 9.52%. For the next nine years, the forecast is for EBITDA to grow by 34.34%.

2022 EBITDA Forecast
$4.98B
2023 EBITDA Forecast
$5.49B
2024 EBITDA Forecast
$5.98B
2025 EBITDA Forecast
$6.62B
2026 EBITDA Forecast
$6.02B
2027 EBITDA Forecast
$5.86B
2028 EBITDA Forecast
$5.92B
2029 EBITDA Forecast
$6.15B
2030 EBITDA Forecast
$6.11B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LHCG Stock Forecast LHC Group Hold 14
$164.80 Buy/Sell $240.55 3.16%
THC Stock Forecast Tenet Healthcare Outperform 15
$44.12 Buy/Sell $82.53 35.99%
TVTY Stock Forecast Tivity Health Hold 13
$32.50 Buy/Sell $27.14 -10.83%

Humana EBIT Forecast for 2022 - 2025 - 2030

In the last three years, Humana's EBIT has grown, increasing from $3.11B to $4.28B – a growth of 37.44%. The next year looks promising for Humana, with analysts predicting EBIT of $4.30B – an increase of 0.63%. Over the next nine years, experts anticipate that Humana's EBIT will grow at a rate of 79.59%.

2022 EBIT Forecast
$4.30B
2023 EBIT Forecast
$4.79B
2024 EBIT Forecast
$5.29B
2025 EBIT Forecast
$5.61B
2026 EBIT Forecast
$5.98B
2027 EBIT Forecast
$6.38B
2028 EBIT Forecast
$6.79B
2029 EBIT Forecast
$7.22B
2030 EBIT Forecast
$7.68B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GTS Stock Forecast Triple-S Management - 7
$35.53 Buy/Sell $19.00 -79.79%
AMBEA Stock Forecast Ambea AB (publ) Buy 18
kr50.60 Buy/Sell kr0.00 48.22%
RAD Stock Forecast Rite Aid Underperform 11
$6.88 Buy/Sell $12.67 1.74%

Humana EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, EPS for Humana has grown by 41.86%, going from $14.55 to $20.64. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $24.15 – an increase of 17.01%. Over the next nine years, experts anticipate that EPS growth for Humana will be 177.42%.

2022 EPS Forecast
$24.15
2023 EPS Forecast
$27.42
2024 EPS Forecast
$30.78
2025 EPS Forecast
$35.10
2026 EPS Forecast
$39.25
2027 EPS Forecast
$42.34
2028 EPS Forecast
$47.01
2029 EPS Forecast
$51.91
2030 EPS Forecast
$57.26
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ATT Stock Forecast Attendo AB (publ) Outperform 14
kr31.80 Buy/Sell kr0.00 38.36%
RXMD Stock Forecast Progressive Care - 0
$0.03 Buy/Sell $0.00 0.00%
SSY Stock Forecast SunLink Health Systems - 0
$1.27 Buy/Sell $0.00 16.54%